Calliditas Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Apr 25 16:11 ET
Calliditas Therapeutics | 20-F: Registration statement / Annual report / Transition report
Apr 24 22:20 ET
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 6 16:11 ET
Calliditas Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Feb 21 16:09 ET
Calliditas Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Jan 8 00:00 ET
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 27, 2023 00:00 ET
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 20, 2023 17:13 ET
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 11, 2023 16:05 ET
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Nov 30, 2023 16:05 ET
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Nov 24, 2023 16:05 ET
Calliditas Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Nov 7, 2023 16:05 ET
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Oct 23, 2023 16:05 ET
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Oct 5, 2023 16:05 ET
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Sep 27, 2023 16:04 ET
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Aug 18, 2023 16:05 ET
Calliditas Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Aug 17, 2023 16:05 ET
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jul 17, 2023 16:05 ET
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jun 21, 2023 16:05 ET
Calliditas Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Jun 12, 2023 16:06 ET
Calliditas Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jun 8, 2023 16:05 ET
No Data
No Data